Your browser doesn't support javascript.
loading
Identification of Actionable Fusions as an Anti-EGFR Resistance Mechanism Using a Circulating Tumor DNA Assay.
Clifton, Katherine; Rich, Thereasa A; Parseghian, Christine; Raymond, Victoria M; Dasari, Arvind; Pereira, Allan Andresson Lima; Willis, Jason; Loree, Jonathan M; Bauer, Todd M; Chae, Young Kwang; Sherrill, Gary; Fanta, Paul; Grothey, Axel; Hendifar, Andrew; Henry, David; Mahadevan, Daruka; Nezami, Mohammad Amin; Tan, Benjamin; Wainberg, Zev A; Lanman, Richard; Kopetz, Scott; Morris, Van.
Afiliación
  • Clifton K; The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Rich TA; GuardantHealth, Redwood City, CA.
  • Parseghian C; The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Raymond VM; GuardantHealth, Redwood City, CA.
  • Dasari A; The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Pereira AAL; The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Willis J; The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Loree JM; BC Cancer, Vancouver, British Columbia, Canada.
  • Bauer TM; Tennessee Oncology Sarah Cannon Research Institute, Nashville, TN.
  • Chae YK; Northwestern University Feinberg School of Medicine, Chicago, IL.
  • Sherrill G; Cone Health Cancer Center, Greensboro, NC.
  • Fanta P; University of San Diego Moores Cancer Center, La Jolla, CA.
  • Grothey A; The University of Tennessee West Cancer Center, Memphis, TN.
  • Hendifar A; Cedars-Sinai Medical Center, Los Angeles, CA.
  • Henry D; University of Pennsylvania, Philadelphia, PA.
  • Mahadevan D; The University of Arizona Cancer Center, Tucson, AZ.
  • Nezami MA; Pacific Medical Center of Hope, Fresno, CA.
  • Tan B; Washington University School of Medicine, St Louis, MO.
  • Wainberg ZA; University of California Los Angeles, Los Angeles, CA.
  • Lanman R; GuardantHealth, Redwood City, CA.
  • Kopetz S; The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Morris V; The University of Texas MD Anderson Cancer Center, Houston, TX.
Article en En | MEDLINE | ID: mdl-33015522

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Revista: JCO Precis Oncol Año: 2019 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Revista: JCO Precis Oncol Año: 2019 Tipo del documento: Article